What action is required when a tissue bank identifies a distributed allograft that may pose a risk to recipients?
-
A
Issue an urgent medical device report only
-
B
Initiate a formal recall and document all notification and retrieval activities
-
C
Wait for recipients to report adverse events
-
D
Notify only the FDA and take no other action